Tom Boyd – Chairman
Mr. Boyd has served on the Company’s Board of Directors since the Company was incorporated in April 2005. He is the founder and past CEO of Fi-Shock, Inc., founder and past CEO of Mark Electronics, founder and past CEO of I-Shop, Inc, and founder and past CEO of The Boyd Group. Mr. Boyd has served as a Director of Radio Systems, Inc. (PetSafe™) since it’s organization in 1991.
Eric Mayer – Chief Executive Officer
Prior to EDP Biotech, Eric Mayer has directed business development at BioPet Vet Lab, EDP Biotech and developed veterinary diagnostic products at AAD, Inc. His experience in human healthcare includes project management at Metabolon, Inc., and pharmaceutical development at Cirrus Pharmaceuticals. He received his Bachelor’s in Biochemistry from UNC-Chapel Hill, and his Master’s of Microbial Biotechnology (MMB) and Master’s of Business Administration (MBA) from North Carolina State University.
Tommye Jordan – Vice President, Research and Development
Tommye Jordan has served as Vice President of Research and Development with EDP since 2005. Prior to EDP, Mrs. Jordan established and served as President of JCL Clinical Research Corporation in 1971-2005 and Concepto Diagnostics in 1990-2005. Mrs. Jordan , a University of Tennessee graduate, is an ASCP medical technologist of 53 years. She served as Research Assistant at University of Tennessee Memorial Research Center Erythropoietin Laboratories and developed the first commercial immunoassay for Erythropoietin. Mrs. Jordan has over 45 peer reviewed publications – including 13 publications on the ColoMarker technology, invited presentations, and holds the American Society of Clinical Pathology Scientific Award 1969. She holds 2 patents in the Immunology Assay field. Mrs. Jordan was Principal Investigator on National Cancer Institute Grant # R43CA36650-01A1 for the development of the tumor marker ELISA presently trademarked ColoMarker.
Dennis Forbush – Director, QA/RA and Manufacturing Liason
Dennis Forbush is currently the Director of QA/RA and Manufacturing Liaison for EDP Biotech and is responsible for the implementation and oversight of the Quality Management System and Contract Management. The Regulatory Affairs responsibilities include review of CE Certification and 510(k) submissions.
During his ten year tenure in the Healthcare and Biotech industry, Dennis’s roles have included Quality and Compliance Officer, Project Manager and Quality Engineer with additional responsibilities as the Management Representative with specific focus on CAPA, the Customer Complaint Handling System, Document Control, Internal Audits and Training Programs. As the Safety Officer, he implemented and maintained the Environmental, Health and Safety Program as well as the Radiation Safety Program. His efforts have culminated into ISO 13485 and CMDCAS Certifications. Dennis holds a B.A. in Organizational Management from Concordia University in St Paul, MN and an A.A. in Aerospace Engineering from the US Air Force.
Anton Jansen – Vice President, International Sales
Anton Jansen has 25 years of experience in the global medical device healthcare industry with demonstrated success in developing new international markets for innovative diagnostic products to include the PLAC Test for diaDexus; respiratory and sleep apnea devices for Tyco Healthcare (now Covidien); and Lipid Point of Care devices for Cholestech. He has built strong relationships with key opinion leaders with expertise in organizing clinical studies and seminars at major conferences. He has a B.S. in Chemistry and M.S. in Biochemistry from The Netherlands. Anton moved in 1995 to the US and is fluent in Dutch and German.
Olivia McGhee – Director, Finance and Operations
Olivia McGhee, a Knoxville native, comes to EDP Biotech with more than 20 years of Accounting and Business Management experience. Her tenure at prior companies such as Lauren Engineers & Constructors and AMEC Engineers, has provided an accomplished skill set widespread in these areas. Because of a take action and teamwork mentality she has excelled and helped management succeed to meet goals. Her community focus involves various organizations including her church and Little League. Along with her faith, personality and hard work ethic, Olivia brings an excitement and energy to the company in helping it thrive and grow to the next level.
Lisa Jensen-Long – Consultant
Lisa Jensen-Long has 25 years of experience with global commercialization in upstream and downstream marketing for both multi-national and start-up organizations. She has led life science and IVD marketing in product discovery, development and international commercialization with assays and platforms for Roche, HTG Molecular and Qiagen. She has demonstrated success in branding, creating both product and corporate awareness and driving customer engagement. She has driven regulatory and payer approvals in the US and internationally for IVD and CDx products in a variety of technology platforms. Lisa holds degrees from the University of Southern California and Arizona State University.